Immunosuppressant drugs for myasthenia gravis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 1, 2009, Pages

  Hart, K ^a   Sharshar, T ^b   Sathasivam, S ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; META ANALYSIS; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION; RANDOMIZED CONTROLLED TRIAL; REVIEW;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYASTHENIA GRAVIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 58249089519     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.144980     Document Type: Article

References (2)

1. Tindall RSA, Rollins JA, Greenlee RG, et al. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis New Eng J Med 1987; 316:719-24.
2. Tindall RS, Phillips JT, Rollins JA, et al. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 1993; 681:539-51